Clinical meaning
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection (Sepsis-3 definition, 2016). The cytokine storm represents the pathological amplification of the innate immune response that drives the transition from localized infection to systemic inflammatory response syndrome (SIRS) and ultimately septic shock with multi-organ dysfunction.
The sepsis cascade begins when pathogen-associated molecular patterns (PAMPs) — such as lipopolysaccharide (LPS/endotoxin) from gram-negative bacteria or lipoteichoic acid from gram-positive organisms — bind to pattern recognition receptors (PRRs) on innate immune cells, primarily toll-like receptors (TLRs) on macrophages, monocytes, and dendritic cells. TLR4 recognizes LPS; TLR2 recognizes gram-positive cell wall components. This binding activates intracellular signaling cascades (NF-κB, MAPK pathways), triggering massive release of pro-inflammatory cytokines: TNF-α (tumor necrosis factor alpha), IL-1β (interleukin-1 beta), and IL-6 (interleukin-6). These early-response cytokines amplify the inflammatory signal by recruiting neutrophils, activating complement (C3a, C5a), and stimulating the coagulation cascade.
Capillary leak syndrome is a hallmark of sepsis pathophysiology. Pro-inflammatory mediators damage the endothelial glycocalyx — the protective carbohydrate-rich layer lining vascular endothelium — and disrupt endothelial cell tight junctions. TNF-α and IL-1β increase endothelial permeability by reorganizing the actin cytoskeleton and degrading junctional proteins (VE-cadherin, occludins). This results in extravasation of plasma proteins and fluid from the intravascular to the interstitial space, causing distributive hypovolemia (intravascular volume depletion despite total body fluid overload), tissue edema, and third-spacing. Clinically, this manifests as hypotension refractory to fluid resuscitation, requiring vasopressor support.